Biocure Technology Inc.
Canadian Securities ExchangeTotal Valuation
Biocure Technology Inc. carries a market capitalization of 408,018.00, placing it among publicly traded companies globally. Its enterprise value stands at 17,295.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 408,018.00 |
| Enterprise Value | 17,295.00 |
Share Statistics
Biocure Technology Inc. currently has 20.21M shares outstanding.
| Shares Outstanding | 20.21M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Biocure Technology Inc. maintains a current ratio of 0.10, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.73, indicating elevated leverage, while an interest coverage ratio of -8.56 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.10 |
| Quick Ratio | 0.10 |
| Debt / Equity | 3.73 |
| Debt / EBITDA | -0.65 |
| Interest Coverage | -8.56 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -5.14 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Biocure Technology Inc.'s stock has declined approximately -85.71429% over the past 52 weeks. The 50-day moving average sits at - -, while the 200-day moving average is - -.
| Beta (5Y) | N/A |
| 52-Week Price Change | -85.71429% |
| 50-Day Moving Average | - - |
| 200-Day Moving Average | - - |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -90,865.00, while operating income came in at -90,865.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -90,865.00 |
| Pretax Income | -102,861.00 |
| Net Income | -102,861.00 |
| EBITDA | -90,865.00 |
| EBIT | -90,865.00 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Biocure Technology Inc. holds 41,425.00 in cash and equivalents against 58,720.00 in total debt, resulting in a net debt position of 17,295.00. Total book value stands at -5.92M, with working capital of -389,541.00 providing operational flexibility.
| Cash & Cash Equivalents | 41,425.00 |
| Total Debt | 58,720.00 |
| Net Debt | 17,295.00 |
| Equity (Book Value) | -5.92M |
| Book Value Per Share | -0.46 |
| Working Capital | -389,541.00 |
Cash Flow
Biocure Technology Inc. produced -76,524.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -76,524.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -76,524.00 |
| FCF Per Share | -0.01 |
Stock Splits
Biocure Technology Inc.'s most recent stock split took place on October 28, 2024 with a 9:1 split ratio.
| Last Split Date | 10/28/2024 |
| Split Ratio | 9:1 |
Scores
Biocure Technology Inc. posts an Altman Z-Score of -17.05, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -17.05 |